trending Market Intelligence /marketintelligence/en/news-insights/trending/Ng5CblpgNCJlbGtr2a_6Ag2 content esgSubNav
In This List

GSK exec joins Novelion Therapeutics as EVP/head of R&D

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


GSK exec joins Novelion Therapeutics as EVP/head of R&D

Murray Stewart will become Novelion Therapeutics Inc.'s executive vice president and head of research and development Nov. 27.

Stewart is joining Novelion Therapeutics from GlaxoSmithKline plc, where he serves as the chief medical officer.